OTCPK:APNHY (South Africa)
Â
Business Description
Aspen Pharmacare Holdings Ltd
Compare
Compare
Traded in other countries / regions
LDZA.Germany
•
APN.South Africa
•
APNHF.USA
Description
Aspen Pharmacare Holdings Ltd is a South African-based global specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The group's commercial pharmaceuticals business comprises Sterile Focus and Regional Brands. Aspen has invested in strategically relevant manufacturing capacity and has capabilities across biological and chemical APIs, orals, liquids, topicals and steriles, at 23 manufacturing facilities on 6 continents.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | 0.64 | |||||
| Debt-to-Equity | 0.31 | |||||
| Debt-to-EBITDA | 2.5 | |||||
| Interest Coverage | 11.56 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.4 | |||||
| Beneish M-Score | -2.33 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.1 | |||||
| 3-Year EBITDA Growth Rate | 22.2 | |||||
| 3-Year EPS without NRI Growth Rate | 57.3 | |||||
| 3-Year FCF Growth Rate | 3.7 | |||||
| 3-Year Book Growth Rate | 10.3 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.84 | |||||
| 9-Day RSI | 44.67 | |||||
| 14-Day RSI | 49.54 | |||||
| 6-1 Month Momentum % | -19.45 | |||||
| 12-1 Month Momentum % | -43.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.48 | |||||
| Quick Ratio | 0.8 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 267.16 | |||||
| Days Sales Outstanding | 90.42 | |||||
| Days Payable | 99.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.17 | |||||
| Dividend Payout Ratio | 0.18 | |||||
| 3-Year Dividend Growth Rate | -6 | |||||
| Forward Dividend Yield % | 2.17 | |||||
| 5-Year Yield-on-Cost % | 2.17 | |||||
| 3-Year Average Share Buyback Ratio | 0.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.42 | |||||
| Operating Margin % | 22.89 | |||||
| Net Margin % | 16.81 | |||||
| ROE % | 9.33 | |||||
| ROA % | 5.75 | |||||
| ROIC % | 6.87 | |||||
| ROC (Joel Greenblatt) % | 28.16 | |||||
| ROCE % | 10.28 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.19 | |||||
| PE Ratio without NRI | 9.19 | |||||
| Shiller PE Ratio | 10.25 | |||||
| Price-to-Owner-Earnings | 35.31 | |||||
| PEG Ratio | 11.49 | |||||
| PS Ratio | 1.69 | |||||
| PB Ratio | 0.9 | |||||
| Price-to-Tangible-Book | 5.19 | |||||
| Price-to-Free-Cash-Flow | 24.2 | |||||
| Price-to-Operating-Cash-Flow | 12.08 | |||||
| EV-to-EBIT | 8.28 | |||||
| EV-to-EBITDA | 8.28 | |||||
| EV-to-Revenue | 1.91 | |||||
| EV-to-FCF | 30.91 | |||||
| Price-to-Projected-FCF | 0.81 | |||||
| Price-to-Median-PS-Value | 0.49 | |||||
| Price-to-Graham-Number | 1.52 | |||||
| Earnings Yield (Greenblatt) % | 12.08 | |||||
| Forward Rate of Return (Yacktman) % | 4.91 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:APNHY
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,435.239 | ||
| EPS (TTM) ($) | 0.903 | ||
| Beta | 1.13 | ||
| Volatility % | 24.79 | ||
| 14-Day RSI | 49.54 | ||
| 14-Day ATR ($) | 0.09614 | ||
| 20-Day SMA ($) | 8.35125 | ||
| 12-1 Month Momentum % | -43.42 | ||
| 52-Week Range ($) | 7.4 - 15.38 | ||
| Shares Outstanding (Mil) | 444.95 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aspen Pharmacare Holdings Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aspen Pharmacare Holdings Ltd Analysis
Share your researchHeadlines
See More
No news.